Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine. - Test2 - elhamkhani - TriplyDB

Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine.

Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine.

http://www.wikidata.org/entity/Q33835015

about

Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012.Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.Toward a new vaccine for pertussis Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis.Complex correlates of protection after vaccination.Pertussis: pertussis control strategies and the options for improving current vaccines.Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis.The pertussis problem.

P2860

Q34489424-871967B2-5E2C-4AF6-92B1-432F8B6C6D62 Q35867061-CCCA78FE-45C5-4DC5-B379-C8FDBC553A72 Q37628007-3215B76A-F1E2-423C-A549-B7CD32FF914D Q38235833-16085486-EAA4-46E8-A065-3FFD606E05D3 Q38456515-D16489D5-91C3-4CD8-9169-29E96F944641 Q44324857-27E558B0-23EF-4355-9E4F-6B5608BD6D99 Q54235766-42EC52DF-AF4F-495A-8A5C-194C569DBBC4 Q54406017-16D976F6-F62C-4E59-8370-ADCE7A03719F

P2860

Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine.

http://www.wikidata.org/entity/Q33835015

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Oligosaccharide conjugates of ...... addition to pertussis vaccine.

@ast

Oligosaccharide conjugates of ...... addition to pertussis vaccine.

@en

type

label

Oligosaccharide conjugates of ...... addition to pertussis vaccine.

@ast

Oligosaccharide conjugates of ...... addition to pertussis vaccine.

@en

prefLabel

Oligosaccharide conjugates of ...... addition to pertussis vaccine.

@ast

Oligosaccharide conjugates of ...... addition to pertussis vaccine.

@en

P1433

Q33835015-F8D40BF6-C3B9-424A-A6F7-BA6AED627023

P1476

Q33835015-CD55BE83-249D-48B4-86B4-CA9686FA6195

P2093

Q33835015-09791C4E-D8CA-46DD-BEF6-E6391E23A462

Q33835015-4320B8E3-6EBF-4BF0-B846-D0967D358CBF

Q33835015-4E03DF26-9481-46C6-A6D9-0110C4DB142D

Q33835015-643E04F5-C4D2-49EE-B690-4DF007169BA6

Q33835015-7D75F454-E085-485B-BCEF-08DB68CE2881

Q33835015-891FAF76-7697-4956-B822-15416BF2CC03

Q33835015-A24AB30E-08CB-4788-9865-33D6EBE5EEED

Q33835015-D47C98EB-77DE-46B3-ACB0-8060F36D59E2

Q33835015-D6EFC225-3658-49ED-BB8D-74CA2B267BC7

P2860

Q33835015-0072E821-412B-4B8E-B4D0-C520F0D20EDA

Q33835015-0133D0DE-5EBA-4D4B-9B67-3CD69E5029E9

Q33835015-051C59A6-5341-4A56-8A70-1197692A0B1A

Q33835015-08CC4807-8F74-461E-96AB-AFCE8B2DD09A

Q33835015-1B0D84B0-EAC7-4F3D-8E0A-0518B998E23D

Q33835015-3205A509-7CA7-4CFA-9387-35CB87096987

Q33835015-32D44F69-9B7C-4C48-8BFB-E39B275E3B1D

Q33835015-34ED912F-1A6F-4550-BBC1-9E3B4A473240

Q33835015-4DDBEEA6-7A2C-46C3-8AA6-EC9CC0A68921

Q33835015-6CFF23D8-FBC5-41B4-B481-86B3F468C040

P304

Q33835015-B9EA0AD9-2586-4525-8A46-3FED62E0F413

P31

Q33835015-5D9788CB-BC96-4D7B-BC58-80FD5B49B221

P356

Q33835015-DC0DE27A-B897-4DCF-A828-8883F1D56942

P407

Q33835015-3944E5B4-1AAC-46DB-A923-27AEDD76E76D

P433

Q33835015-4ACD3E73-F82E-426E-AE3C-04EEC8253F9A

P478

Q33835015-AF695A2D-CEBF-495E-8CD3-43AC11A80CC4

P50

Q33835015-E50ABF51-348A-432D-8232-3116AABB3F32

Q33835015-E75324FE-5D93-4E71-B17A-8C09DDE25110

P577

Q33835015-659730E3-A615-4A32-B23C-473A557CAD9C

P5875

Q33835015-1B109658-0565-4E50-8812-7D97D8A14BCD

P698

Q33835015-235BDFAC-FC84-485B-ABE8-6A8A5C8EED7C

P921

Q33835015-662A33FC-E417-4526-8F8F-3B12959AB13F

Q33835015-67FB36DA-908C-4672-85F5-50CF60C554C7

P932

Q33835015-B6F2358F-67E9-4CB3-ADD6-106A28C03F08

P356

PNAS.1100782108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Oligosaccharide conjugates of ...... addition to pertussis vaccine.

@en

P2093

Andrew Preston

http://www.w3.org/2001/XMLSchema#string

Ariel Ginzberg

http://www.w3.org/2001/XMLSchema#string

Duncan J Maskell

http://www.w3.org/2001/XMLSchema#string

Evgeny Vinogradov

http://www.w3.org/2001/XMLSchema#string

Jerry D King

http://www.w3.org/2001/XMLSchema#string

Jerry M Keith

http://www.w3.org/2001/XMLSchema#string

John B Robbins

http://www.w3.org/2001/XMLSchema#string

Teresa Lagergård

http://www.w3.org/2001/XMLSchema#string

Vince Pozsgay

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1

A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates.

Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoid

Immunochemical studies of Shigella flexneri 2a and 6, and Shigella dysenteriae type 1 O-specific polysaccharide-core fragments and their protein conjugates as vaccine candidates.

Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis

Structural variability and originality of the Bordetella endotoxins.

Epitope of the vaccine-type Bordetella pertussis strain 186 lipooligosaccharide and antiendotoxin activity of antibodies directed against the terminal pentasaccharide-tetanus toxoid conjugate.

Pertussis vaccine: a critique.

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.

P304

4087-4092

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1100782108

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Rachel Schneerson

Joanna Kubler-Kielb

P577

2011-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50266697

http://www.w3.org/2001/XMLSchema#string

P698

21367691

http://www.w3.org/2001/XMLSchema#string

P921

Bordetella pertussis

oligosaccharide

P932

3054038

http://www.w3.org/2001/XMLSchema#string